Concepedia

Christopher L. Carpenter

CL

36

Publications

5.5K

Citations

28

H-Index

1993

Active since

Affiliations

Harvard University(Current)

Beth Israel Deaconess Medical Center

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Beth Israel Deaconess Hospital

Christopher L. Carpenter is an author at Harvard University specializing in medicine, cell signaling, and signal transduction.

Top concepts

Publications per year

1993–2021

36

Publications

36

Rac Homologues and Compartmentalized Phosphatidylinositol 4, 5-Bisphosphate Act in a Common Pathway to Regulate Polar Pollen Tube Growth

Benedikt Kost, Emmanuel Lemichez, Pius Spielhofer et al. · The Journal of Cell Biology · 1999 · 563 citations · Full text

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen Sandhu, William R. Schelman, George Wilding et al. · The Lancet Oncology · 2013 · 551 citations

, , +7

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

Hongbing Zhang, Gregor Cicchetti, Hiroaki Onda et al. · Journal of Clinical Investigation · 2003 · 497 citations · Full text

, , +14

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

Hongbing Zhang, Gregor Cicchetti, Hiroaki Onda et al. · Journal of Clinical Investigation · 2003 · 477 citations · Full text

Rho Family GTPases Bind to Phosphoinositide Kinases

Kimberley F. Tolias, Lewis C. Cantley, Christopher L. Carpenter · Journal of Biological Chemistry · 1995 · 467 citations · Full text

Rows per page

1–5 of 36